Developments in inhaled combination therapies: patent activity 2013 – 2014

Expert Opinion on Therapeutic Patents ◽

10.1517/13543776.2015.1064394 ◽

2015 ◽

pp. 1-7

Author(s):

Peter Norman

Keyword(s):

Combination Therapies ◽

Patent Activity

Download Full-text

Two Combination Therapies Equal for Acne

Internal Medicine News ◽

10.1016/s1097-8690(10)70741-1 ◽

2010 ◽

Vol 43 (14) ◽

pp. 35

Author(s):

HEIDI SPLETE

Keyword(s):

Combination Therapies

Download Full-text

Combination therapies in the treatment of sexual dysfunction

PsycEXTRA Dataset ◽

10.1037/e512622013-006 ◽

2011 ◽

Author(s):

Michael A. Perelman

Keyword(s):

Sexual Dysfunction ◽

Combination Therapies

Download Full-text

Combination Therapies Equal For Reducing Acne Lesions

Family Practice News ◽

10.1016/s0300-7073(10)70964-6 ◽

2010 ◽

Vol 40 (15) ◽

pp. 56

Author(s):

HEIDI SPLETE

Keyword(s):

Combination Therapies

Download Full-text

New combination therapies for castration-resistant prostate cancer

Oncology Abstracts ◽

10.1530/oncolabs.1.p031 ◽

2019 ◽

Author(s):

Mitchell G Lawrence ◽

Laura H Porter ◽

Daisuke Obinata ◽

Shahneen Sandhu ◽

Luke A Selth ◽

...

Keyword(s):

Prostate Cancer ◽

New Combination ◽

Combination Therapies ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

A Study by the Development of Triple Artemisinin Combination Therapies (DeTACT) Collaboration (Africa)

Case Medical Research ◽

10.31525/ct1-nct03923725 ◽

2019 ◽

Author(s):

Keyword(s):

Combination Therapies ◽

Artemisinin Combination Therapies

Download Full-text

Faculty Opinions recommendation of Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3447957.3171054 ◽

2010 ◽

Author(s):

Takahiko Nakagawa

Keyword(s):

High Risk ◽

Randomised Controlled Trial ◽

Cardiovascular Events ◽

Controlled Trial ◽

Secondary Analysis ◽

Fixed Dose Combination ◽

Combination Therapies ◽

Dose Combination ◽

Randomised Controlled

Download Full-text

Faculty Opinions recommendation of Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717973390.793470110 ◽

2013 ◽

Author(s):

Jin-Xiong She ◽

Wenbo Zhi

Keyword(s):

Drug Discovery ◽

Agile Development ◽

Combination Therapies

Download Full-text

Patent Intensity and Concentration: The Effect of Institutional Quality on MSA Patent Activity

SSRN Electronic Journal ◽

10.2139/ssrn.3365314 ◽

2019 ◽

Author(s):

Gary A. Wagner ◽

Jamie Bologna Pavlik

Keyword(s):

Institutional Quality ◽

Patent Activity

Download Full-text

Pancreatic Cancer: Systemic Combination Therapies for a Heterogeneous Disease

Current Pharmaceutical Design ◽

10.2174/1381612820666140826154327 ◽

2014 ◽

Vol 20 (42) ◽

pp. 6660-6669 ◽

Author(s):

Davide Melisi ◽

Lorenzo Calvetti ◽

Melissa Frizziero ◽

Giampaolo Tortora

Keyword(s):

Pancreatic Cancer ◽

Combination Therapies

Download Full-text

All Oral Interferon-free Direct-acting Antivirals as Combination Therapies to Cure Hepatitis C

Current Molecular Medicine ◽

10.2174/1566524019666190104110439 ◽

2019 ◽

Vol 18 (7) ◽

pp. 409-435 ◽

Author(s):

Imran Shahid ◽

Munjed M. Ibrahim

Keyword(s):

Hepatitis C ◽

Combination Therapies ◽

Direct Acting Antivirals ◽

Download Full-text